CLINICAL_TRIALS
trial_result
· 2021-11-17
Clinical Trial Update: everlinQ endoAVF Post Market Study [NA]
Summary
Post-market study update for the everlinQ endoAVF in chronic kidney disease. The study was terminated and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: C. R. Bard | Conditions: Chronic Kidney Disease | NA | Status: TERMINATED | Results posted: 2021-11-17